To assess the role of the aerobactin-related system in the virulence of bovine opportunistic Escherichia coli, and to determine the stage(s) of the overall infectious process at which it is acting, germfree lambs were mixedly infected orally with two derivative strains of this bacterium differing in their ability (Iut+) or inability (lut-) to express a functional aerobactin-mediated iron transport system. The Iut-strain was compared with the Iut+ strain for colonization of the gut, translocation to the mesenteric lymph nodes (MLN), and spread to other organs and to the body fluids of diassociated lambs. The Iut-mutant was found in smaller numbers in the duodenum, suggesting that aerobactin conferred a significant selective advantage for colonization of this intestinal segment. Although the two challenge strains translocated to MLN, the population level in the MLN was always higher for the Iut+ strain. Moreover, experimental infections resulted in recovery of only the Iut+ strain in the organs other than the MLN and in the body fluids. These results indicate a role for aerobactin in promoting systemic spread of the bacteria from the intestine. Direct evidence was obtained that aerobactin secretion occurred in vivo at both intestinal and extraintestinal sites of infection. In contrast to enterobactin, aerobactin was detected in the duodenum, jejunum, ileum, cecum, liver, spleen, kidney, urine, cerebrospinal fluid, and bile. The highest concentration of aerobactin was found in the urine, even when the samples were devoid of infecting bacteria. All of these findings suggest that aerobactin is released in vivo in a diffusible form and that it may be an important step in the production of disease by intestinal opportunistic E. coli.
Bacterial virulence is an essentially multifactorial phenomenon (29) , and iron starvation is one of the major barriers that virulent bacteria must overcome in order to proliferate in the host (5, 33) . Part of the host response to infection is to further reduce the amount of iron available to the invading pathogen by decreasing intestinal iron absorption, synthesizing additional iron proteins, and shifting iron from the plasma pool into intracellular storage (16, 21, 32) . Thus, before infections can develop in the host, pathogenic bacteria must adapt to the low-iron environment in vivo, and special iron chelation systems are necessary for growth and survival. These systems include the production of siderophores (4) which are capable of binding iron with very high affinity and delivering this iron to the bacterium to satisfy its nutritional needs. In Escherichia coli, the aerobactin proves to be the most effective siderophore for iron acquisition (15, 36) . The incidence of aerobactin in E. coli strains causing extraintestinal infections in both humans and animals is remarkably high, and the highest percentage of aerobactinproducing E. coli strains is always found in blood and urine (14) . These epidemiological data form the basis for defining aerobactin as an important contributor to extracellular pathogenesis. However, there are no published studies showing direct evidence that aerobactin is produced in the host and thereby may influence the outcome of an infection. In addition, a limited number of reports (35, 38) in which the role of aerobactin in virulence of E. coli has been unequivocally determined by exposing animals to E. coli strains * Corresponding author. differing only in their ability or inability to secrete aerobactin have been published. Unfortunately, the results from these few studies using the peritonitis model in mice for experimental infections are not sufficient to identify the stage of the infectious process at which the selective advantage provided by aerobactin production may operate.
The purpose of the work reported here was to further assess the role of aerobactin in the virulence of an opportunistic pathogen strain of E. coli which was isolated from feces of diarrheic calves and capable of causing septicemia in gnotobiotic calves (9) and lambs (8) . Many animal and human studies demonstrate that the gastrointestinal (GI) tract is a reservoir for opportunistic bacterial infections in the compromised host (31) . Indeed, direct evidence linking bacterial translocation and intestinal overgrowth has been obtained from models that involve gnotobiotic animals (34) . Moreover, the literature contains many reports documenting that in experimental animals, intestinal overgrowth of orally inoculated translocating bacteria can result in systemic infection (34) . Thus, bacterial translocation from the GI tract to the mesenteric lymph nodes (MLN) and other organs is undoubtedly an important initial step in the pathogenesis of many bacterial diseases. Although aerobactin is currently viewed as a virulence factor promoting bacterial proliferation at the extraintestinal sites of infection, its role in the bacterial colonization of the gut and in the systemic spread of bacteria from the intestine is unknown. To clarify this point, germfree newborn lambs were mixedly infected orally with two derivative strains of E. coli differing in their ability to express a functional aerobactin-mediated iron transport system. We evaluated the influence of the aerobactin system (9) and lambs (8) . This strain contains a 184-kb plasmid, p31A, which carries the aerobactin biosynthesis and transport genes, as assessed by the cross-feeding and cloacin sensitivity tests (this work). Plasmid p31A confers resistance to streptomycin, kanamycin, chloramphenicol, tetracycline, and sulfamides. It also specifies production of CS31A, a new K88-related surface antigen (17) . However (24) or MacConkey agar medium (Difco Laboratories, Detroit, Mich.) or in M9-CA medium, which is a M9 minimal-salts medium (24) supplemented with 0.2% glucose, 50 ,ug of thiamine per ml, and 0.5% Casamino Acids (Difco). For growth of aroB strains, the M9-CA medium was supplemented with 100 ,ug of tryptophan per ml, 100 ,ug of tyrosine per ml, 100 ,ug of phenylalanine per ml, 0.2 mMp-aminobenzoic acid, 0.2 mM p-hydroxybenzoic acid, and, if needed, 1 mM sodium citrate. Antibiotics were used at the following final concentrations: streptomycin, 30 ,ug/ml; kanamycin, 50 ,ug/ml; chloramphenicol, 30 ,ug/ml; tetracycline, 10 ,ug/ml; and nalidixic acid, 40 to 100 ,ug/ml. Iron-limited cultures were obtained by adding either 3.12 ,uM transferrin (Sigma Chemical Co., St. Louis, Mo.) or 200 ,uM 2,2'-dipyridyl (E. Merck AG, Darmstadt, Germany). All liquid cultures were grown at 37°C and aerated by shaking.
Isolation of mutants deleted in aerobactin gene cluster. A 0.5-ml amount of an overnight LB culture of E. coli XA31A was diluted and inoculated into tubes containing 5 ml of the LB medium with various concentrations of ethidium bromide (25 to 125 ,ug/ml). After overnight incubation at 37°C, cells from the tube corresponding to the highest concentration of ethidium bromide still allowing growth were spread as lawns (108 cells) onto nutrient agar plates containing 0.2 mM 2,2'-dipyridyl, 50 ,ug of kanamycin per ml, 40 ,ug of nalidixic acid per ml, and 1 ml of an undiluted crude cloacin DF13 preparation. After overnight incubation at 37°C, cloacinresistant mutants were subjected to biological assays for ferric-aerobactin receptor activity, to biological and chemical assays for aerobactin production, and to antibiotic sensitivity tests. The presence of plasmids harbored by these mutants was demonstrated by DNA extractions and agarose gel electrophoresis. E. coli XA322, showing only one deletion in the aerobactin gene cluster, was thus selected. The size and location of this deletion were determined by using different restriction endonucleases.
Biological assay for ferric-aerobactin receptor activity. The receptor for the ferric-aerobactin complex is also the receptor for cloacin DF13 of Enterobacter cloacae (2 322AN to organs other than the MLN occurred in one lamb, although its MLN population level was similar to that of E. coli LN31A observed in another lamb in which the latter strain did translocate to liver, spleen, and kidney. All of these results indicate a role for aerobactin in the systemic spread of strain LN31A from the intestine.
In vivo siderophore production. To determine whether siderophore secretion occurred in vivo in the five lambs diassociated with strains LN31A and 322AN, contents of different digestive tract areas, homogenates of various organs, and body fluids were assayed for the presence of the aerobactin and enterobactin siderophores. In contrast to aerobactin, enterobactin was lacking in all biological materials examined, although it was produced in vitro by both strains. Aerobactin could not be detected in the MLN and the blood of any animal, but it was present in all other intestinal and extraintestinal contents tested, depending on the diassociation trial (Table 3) . Aerobactin was evidenced in the duodenum of one lamb only (Table 3 , lamb B), possibly resulting from the low level of bacteria populating this intestinal segment in the other animals. The incidence of aerobactin, expressed as the number of samples positive for aerobactin over the number of samples tested, was 5/5 for jejunum, ileum and urine, 4/5 for cecum and bile, 3/5 for kidney, and 2/5 for liver, spleen, and cerebrospinal fluid. The highest growth promotion halo obtained with the aerobactin indicator strain IRA36/80 was found for urine (Table 3,  lambs A and D) . Surprisingly, aerobactin was also detected even in the urine samples devoid of bacteria (Table 2 and  Table 3 , lambs C, D, and E). These results show strong evidence that the plasmid-mediated aerobactin was produced in vivo in a diffusible form. The lack of detection of enterobactin, as assessed by a cross-feeding test using E. coli AB2847N as the indicator strain, indicated that enterobactin was not produced or was weakly produced in vivo or that it was more labile or less diffusible than aerobactin.
Relationship between aerobactin production and rate of Table 4 and Fig. 1 indicate that the rates of translocation of E. coli LN31A from ceca to the MLN increased proportionally with increasing cecal aerobactin production. 
DISCUSSION
Bacterial translocation from the GI tract, through the epithelial mucosa to the MLN, appears to be an important initial step in the pathogenesis of opportunistic infections caused by gram-negative enteric bacteria of the indigenous flora or by exogenous organisms that transiently colonize the GI tract (3, 31) .
Translocation could be due to pinocytosis of bacteria by mucosal epithelial cells, to passive absorption of bacteria, or to certain properties or activities of the bacteria (30) . Once through the epithelial lining of the GI tract, the bacteria travel by the lymphatic system to the MLN and then may disseminate to other organs such as the spleen, liver, or kidney (30) . They may even spread to the bloodstream to cause bacteremia and death (31). Steffen et al. (31) showed that E. coli was associated with a high incidence of bacteremia in debilitated patients, because this bacterium translocates very efficiently from the GI tract. On the other hand, previous studies (20, 25) have demonstrated a high incidence of the aerobactin-mediated iron uptake system in E. coli isolated from patients with bacteremia. The fundamental question of whether aerobactin may play a role in translocation from the GI tract remains to be thoroughly investigated.
In an attempt to address this question, we determined the contribution of aerobactin to intestinal colonization and to translocation from the GI tract by orally diassociating germfree lambs with two E. coli strains which differed in their ability (Iut+ phenotype) or inability (Iut-) to transport the ferric-iron aerobactin complex.
The two challenge strains did translocate to the MLN of all diassociated lambs tested. The relatively high concentration of cecal bacteria in this study might have contributed to a spontaneous translocation from the GI tract to the MLN (30). However, the population level in the MLN was always higher for the Iut+ strain than for the Iut-strain, even when their cecal population levels were similar. In addition, no correlation between the cecal population levels of the infecting bacteria and their numbers in the MLN was found. Therefore, the greater ability of the Iut+ strain than of the Iut-strain to translocate from the GI tract cannot be explained solely on the basis of the cecal population levels but implies the existence of a more effective mechanism. The rate of translocation of the Iut+ strain to the MLN was subject to wide variability. This study demonstrated that the differences observed in the intensity of translocation of the Iut+ strain from the GI tract to the MLN were related to variations in the degree of expression of the aerobactin system. Thus, the Iut+ strain with a functional aerobactin system appears to be more adept in translocating from the GI tract than is the Iut-strain impaired in this system. However, the number of bacteria in the MLN represents translocation as well as subsequent multiplication or killing of the bacteria. Consequently, the Iut+ and Iut-strains may translocate at similar efficiencies, but the Iut+ strain may survive and multiply to a greater extent in the MLN.
Our experiments also showed that the plasmid-mediated aerobactin system conferred a significant selective advantage for colonization of the duodenum, through which bacterial translocation out of the intestinal lumen occurs (34) . It is widely accepted that lactoferrin possesses the ability to give up iron to the small intestine and does so by combining with specific cell surface receptors at the brush border membrane (10) . In accordance with the suggestion of Williams and Roberts (37), we believe it possible that the role of aerobactin in colonization of the small intestine, particularly of the duodenum, is to acquire iron from its complexed state with the lactoferrin in the environment of the intestinal epithelium. Thus, analyzing this work and extrapolating from similar data concerning Shigella flexneri (26) , one can predict that the selective advantage provided by aerobactin production must operate at the stage of multiplication when bacteria live within the extracellular compartment of the intestinal villus.
This study proved unequivocally that aerobactin contributes to bacterial dissemination from the intestine to organs and to body fluids. Indeed, experimental infections of germfree lambs with mixtures consisting of the wild-type strain and the aerobactin receptor-deficient mutant resulted in recovery of only the wild-type strain in organs other than the MLN (liver, spleen, and kidney) and in the body fluids (blood, urine, cerebrospinal fluid, and bile) of all tested lambs. The fact that the mutant bacteria, although present in the MLN, were never detected in these organs suggests that the MLN cleared the lymphatic system of most of these bacteria and then the immune cells in the blood removed the remaining organisms. One can assume that the immune system of gnotobiotic lambs should be more efficient at clearing the viable aerobactin receptor-deficient mutant rather than the viable wild-type strain. We now know (23) that lactoferrin receptors are present on the surface of macrophages, B lymphocytes, mononuclear cells, and polymorphonuclear leukocytes and that macrophages synthesize transferrin also (19 The results presented above show direct evidence that aerobactin was present in the digestive tract, in organs such as the liver, spleen, and kidney, and in body fluids such as urine, cerebrospinal fluid, and bile. The highest concentration of aerobactin was found in the urine even when the samples were devoid of infecting bacteria. This finding argues that aerobactin was secreted in vivo in diffusible form. Thus, the production of aerobactin by E. coli colonizing the GI tract may be an important predisposing factor for further urinary tract infections in hospital patients. Indeed, the aerobactin system is frequently associated with E. coli isolates from serious urinary tract infections in humans, probably because it promotes bacterial growth in the limiting free-iron concentrations encountered in urine (28) . Our observations may also help to explain why a high incidence of aerobactin-producing E. coli strains has been associated with bacteremia in hospital patients (20, 24) .
In conclusion, this study indicates that aerobactin influences either the extent of bacterial translocation from the intestinal tract or the extent of bacterial multiplication in tissues following translocation, or both. Thus, aerobactin secretion in vivo could be an important step in the stages of the infection cycle during which intestine-populating opportunistic bacteria effectively colonize the gut, penetrate the mucous layer covering the intestinal villi, translocate out of the intestinal lumen through the epithelium cells, and finally spread to organs within which they may survive.
